BIO Stock Overview
Biome Australia Limited develops, commercializes, and markets various live biotherapeutics and complimentary medicines in Australia and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Biome Australia Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.32 |
52 Week High | AU$0.43 |
52 Week Low | AU$0.06 |
Beta | 1.53 |
1 Month Change | -9.86% |
3 Month Change | 18.52% |
1 Year Change | 295.06% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 166.67% |
Recent News & Updates
Recent updates
Shareholder Returns
BIO | AU Personal Products | AU Market | |
---|---|---|---|
7D | -16.9% | -5.9% | 0.9% |
1Y | 295.1% | -11.0% | 5.6% |
Return vs Industry: BIO exceeded the Australian Personal Products industry which returned -11% over the past year.
Return vs Market: BIO exceeded the Australian Market which returned 5.6% over the past year.
Price Volatility
BIO volatility | |
---|---|
BIO Average Weekly Movement | 13.7% |
Personal Products Industry Average Movement | 5.3% |
Market Average Movement | 8.9% |
10% most volatile stocks in AU Market | 17.6% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: BIO's share price has been volatile over the past 3 months.
Volatility Over Time: BIO's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | 30 | Blair William Brabin Norfolk | www.biomeaustralia.com |
Biome Australia Limited develops, commercializes, and markets various live biotherapeutics and complimentary medicines in Australia and internationally. It provides live biotherapeutic products under the Activated Probiotics brand; organic nutraceutical products under the Activated Nutrients brand; and sports performance and recovery products under the Activated X Performance brand. The company markets its products through community pharmacies, independent health practitioners, and health professionals.
Biome Australia Limited Fundamentals Summary
BIO fundamental statistics | |
---|---|
Market cap | AU$70.23m |
Earnings (TTM) | -AU$2.86m |
Revenue (TTM) | AU$9.87m |
6.9x
P/S Ratio-23.8x
P/E RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BIO income statement (TTM) | |
---|---|
Revenue | AU$9.87m |
Cost of Revenue | AU$3.96m |
Gross Profit | AU$5.91m |
Other Expenses | AU$8.77m |
Earnings | -AU$2.86m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.013 |
Gross Margin | 59.83% |
Net Profit Margin | -29.03% |
Debt/Equity Ratio | 52.3% |
How did BIO perform over the long term?
See historical performance and comparison